Please login to the form below

Not currently logged in
Email:
Password:

PMCPA launches phase 2 of Code consultation

The Prescription Medicines Code of Practice Authority has published the second part of its consultation on proposed amendments to the ABPI Code of Practice

The Prescription Medicines Code of Practice Authority (PMCPA) has published the second part of its consultation on proposed amendments to the Association of the British Pharmaceutical Industry (ABPI) Code of Practice for the pharmaceutical industry.

This second phase (Appendix 3) was published on August 4, 2010 and includes proposals for increased transparency regarding pharmaceutical companies employing health professionals and others to act as consultants. The consultation period will close on September 14, 2010, with responses requested by the PMCPA by September 1, 2010.

The first phase was published on June 28, 2010 and included proposed amendments for the provision of promotional aids (Appendices 1 and 2).  Responses to phase one must be received by the PMCPA by August 13, 2010.

The Code of Practice applies to the promotion of medicines to members of the UK health professions and appropriate administrative staff.  It also applies to a number of areas which are non-promotional, including information made available to the public about prescription only medicines. The Code was last updated in 2008.

Full consultation documents are available on the PMCPA website. All responses should be sent to consultations@pmcpa.org.uk

5th August 2010

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Weber Shandwick

At Weber Shandwick, engagement has always been the cornerstone of health communications.We make health matter. Health is a basic human...

Latest intelligence

Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
What is blockchain and why should i care - Richard Springham
Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...
NHS medicines optimisation milestone
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry...

Infographics